Mycobacterium tuberculosis exerts gene-selective inhibition of transcriptional responses to IFN-γ without inhibiting STAT1 function

Journal of Immunology

Volumn 171, Issue 4, 2003, Pages 2042-2049

  Kincaid, Eleanor Z ^a   Ernst, Joel D ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD64 ANTIGEN; GAMMA INTERFERON; HISTONE; PROTEIN INHIBITOR; PROTEIN INHIBITOR OF ACTIVATED STAT INTERFERENCE WITH DNA BINDING; SERINE; STAT1 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; TYROSINE; UNCLASSIFIED DRUG;

ACETYLATION; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL INFECTION; CELL CULTURE; CELLULAR IMMUNITY; CONTROLLED STUDY; ERADICATION THERAPY; GAMMA ACTIVATED SEQUENCE; GENE; GENE INACTIVATION; GENE SELECTIVE INHIBITION; GENE SEQUENCE; HUMAN; HUMAN CELL; INFECTION; INTERFERON GAMMA RESPONSE SEQUENCE; INTERFERON GAMMA RESPONSIVE GENE; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; TRANSACTIVATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

EID: 0042635767     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.4.2042     Document Type: Article

References (40)

1. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249.
2. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, and 1. M. Orme. 1993. Disseminated tuberculosis in interferon γ gene-disrupted mice. J. Exp. Med. 178:2243.
3. Jouanguy, E., S. Lamhamedi-Cherradi, D. Lammas, S. E. Dorman, M. C. Fondaneche, S. Dupuis, R. Doffinger, F. Altare, J. Girdlestone, J. F. Emile, et al. 1999. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat. Genet. 21:370.
4. Dupuis, S., R. Doffinger, C. Picard, C. Fieschi, F. Altare, E. Jouanguy, L. Abel, and J. L. Casanova. 2000. Human interferon-γ-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion. Immunol. Rev. 178:129.
5. Barnes, P. F., S. J. Fong, P. J. Brennan, P. E. Twomey, A. Mazumder, and R. L. Modlin. 1990. Local production of tumor necrosis factor and IFN-γ in tuberculous pleuritis. J. Immunol. 145:149.
6. Barnes, P. F., S. Lu, J. S. Abrams, E. Wang, M. Yamamura, and R. L. Modlin. 1993. Cytokine production at the site of disease in human tuberculosis. Infect. Immun. 61:3482.
7. Robinson, D. S., S. Ying, I. K. Taylor, A. Wangoo, D. M. Mitchell, A. B. Kay, Q. Hamid, and R. J. Shaw. 1994. Evidence for a Th1-like bronchoalveolar T-cell subset and predominance of interferon-γ gene activation in pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 149:989.
8. Fenhalls, G., L. Stevens, J. Bezuidenhout, G. E. Amphlett, K. Duncan, P. Bardin, and P. T. Lukey. 2002. Distribution of IFN-γ, IL-4 and TNF-α protein and CD8 T cells producing IL-12p40 mRNA in human lung tuberculous granulomas. Immunology 105:325.
9. Bergeron, A., M. Bonay, M. Kambouchner, D. Lecossier, M. Riquet, P. Soler, A. Hance, and A. Tazi. 1997. Cytokine patterns in tuberculous and sarcoid granulomas: correlations with histopathologic features of the granulomatous response. J. Immunol. 159:3034.
10. Ramana, C. V., M. P. Gil, R. D. Schreiber, and G. R. Stark. 2002. Stat1-dependent and -independent pathways in IFN-γ-dependent signaling. Trends Immunol. 23:96.
11. Byrd, T. F., and M. A. Horwitz. 1989. Interferon γ-activated human monocytes down-regulate transferrin receptors and inhibit the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. J. Clin. Invest. 83: 1457.
12. Murray, H. W., A. M. Granger, and R. F. Teitelbaum. 1991. Interferon activates human macrophages and Toxoplasma gondii, Chlamydia psittaci and Leishmania donovani: antimicrobial role of limiting intracellular iron. Infect. Immun. 59:4684.
13. Douvas, G. S., D. L. Looker, A. E. Vatter, and A. J. Crowle. 1985. γ Interferon activates human macrophage to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria. Infect. Immun. 50:1.
14. Rook, G. A. W., J. Steele, M. Ainsworth, and B. R. Champion. 1986. Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant γ-interferon on human monocytes and murine peritoneal macrophages. Immunology 59:333.
15. Levy, D. E., and J. E. Darnell, Jr. 2002. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 3:651.
16. Decker, T., and P. Kovarik. 2000. Serine phosphorylation of STATs. Oncogene 19:2628.
17. Ting, L. M., A. C. Kim, A. Cattamanchi, and J. D. Ernst. 1999. Mycobacterium tuberculosis inhibits IFN-γ transcriptional responses without inhibiting activation of STAT1. J. Immunol. 163:3898.
18. Nandan, D., and N. E. Reiner. 1997. TGF-β attenuates the class II transactivator and reveals an accessory pathway of IFN-γ action. J. Immunol. 158:1095.
19. Paquette, R. L., M. R. Minosa, M. C. Verma, S. D. Nimer, and H. P. Koeffler. 1995. An interferon-γ activation sequence mediates the transcriptional regulation of the IgG Fc receptor type IC gene by interferon-γ. Mol. Immunol. 32:841.
20. O'Keefe, G. M., V. T. Nguyen, L. L. Ping Tang, and E. N. Benveniste. 2001. IFN-γ regulation of class II transactivator promoter IV in macrophages and microglia: involvement of the suppressors of cytokine signaling-1 protein. J. Immunol. 166:2260.
21. Zhong, G., P. Fan, H. Ji, F. Dong, and Y. Huang. 2001. Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J. Exp. Med. 193:935.
22. Shuai, K., G. R. Stark, I. M. Kerr, and J. E. Darnell, Jr. 1993. A single phosphotyrosine residue of Stat91 required for gene activation by interferon-γ. Science 261:1744.
23. Muller, M., C. Laxton, J. Briscoe, C. Schindler, T. Improta, J. Darnell, Jr., G. Stark, and I. Kerr. 1993. Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-α and -γ signal transduction pathways. EMBO J. 12:4221.
24. Wen, Z., Z. Zhong, and J. E. Darnell, Jr. 1995. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82:241.
25. Yang, E., M. A. Henriksen, O. Schaefer, N. Zakharova, and J. E. Darnell, Jr. 2002. Dissociation time from DNA determines transcriptional function in a STAT1 linker mutant. J. Biol. Chem. 277:13455.
26. Eberharter, A., and P. B. Becker. 2002. Histone acetylation: a switch between repressive and permissive chromatin: second in review series on chromatin dynamics. EMBO Rep. 3:224.
27. Hussain, S., B. S. Zwilling, and W. P. Lafuse. 1999. Mycobacterium avium infection of mouse macrophages inhibits IFN-γ Janus kinase-STAT signaling and gene induction by down-regulation of the IFN-γ receptor. J. Immunol. 163:2041.
28. Ray, M., A. A. Gam, R. A. Boykins, and R. T. Kenney. 2000. Inhibition of interferon-γ signaling by Leishmania donovani. J. Infect. Dis. 181:1121.
29. Liu, B., J. Liao, X. Rao, S. A. Kusher, C. D. Chung, D. D. Chang, and K. Shuai. 1998. Inhibition of Stat1-mediated gene activafion by PIAS1. Proc. Natl. Acad. Sci. USA 95:10626.
30. Noss, E. H., C. V. Harding, and W. H. Boom. 2000. Mycobacterium tuberculosis inhibits MHC class II antigen processing in murine bone marrow macrophages. Cell. Immunol. 201:63.
31. Noss, E. H., R. K. Pai, T. J. Sellati, J. D. Radolf, J. Belisle, D. T. Golenbock, W. H. Boom, and C. V. Harding. 2001. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J. Immunol. 167:910.
32. Ehrt, S., D. Schnappinger, S. Bekiranov, J. Drenkow, S. Shi, T. R. Gingeras, T. Gaasterland, G. Schoolnik, and C. Nathan. 2001. Reprogramming of the macrophage transcriptome in response to interferon-γ and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J. Exp. Med. 194:1123.
33. Sibley, L. D., L. B. Adams, and J. L. Krahenbuhl. 1990. Inhibition of interferon-γ-mediated activation in mouse macrophages treated with lipoarabinomannan. Clin. Exp. Immunol. 80:141.
34. Sibley, L. D., S. W. Hunter, P. J. Brennan, and J. L. Krahenbuhl. 1988. Mycobacterial lipoarabinomannan inhibits γ interferon-mediated activation of macrophages. Infect. Immun. 56:1232.
35. Sibley, L. D., and J. L. Krahenbuhl. 1987. Mycobacterium leprae-burdened macrophages are refractory to activation by γ interferon. Infect. Immun. 55:446.
36. Sibley, L. D., and J. L. Krahenbuhl. 1988. Defective activation of granuloma macrophages from Mycobacterium leprae-infected nude mice. J. Leukocyte Biol. 43:60.
37. Sibley, L. D., and J. L. Krahenbuhl. 1988. Induction of unresponsiveness to γ interferon in macrophages infected with Mycobacterium leprae. Infect. Immun. 56:1912.
38. Chan, J., X. D. Fan, S. W. Hunter, P. J. Brennan, and B. R. Bloom. 1991. Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages. Infect. Immun. 59:1755.
39. Hoft, D. F., S. Worku, B. Kampmann, C. C. Whalen, J. J. Ellner, C. S. Hirsch, R. B. Brown, R. Larkin, Q. Li, H. Yun, and R. F. Silver. 2002. Investigation of the relationships between immune-mediated inhibition of mycobacterial growth and other potential surrogate markers of protective Mycobacterium tuberculosis immunity. J. Infect. Dis. 186:1448.
40. Langermans, J. A., P. Andersen, D. van Soolingen, R. A. Vervenne, P. A. Frost, T. van der Laan, L. A. van Pinxteren, J. van den Hombergh, S. Kroon, I. Peekel, et al. 2001. Divergent effect of bacillus Calmette-Guerin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine research. Proc. Natl. Acad. Sci. USA 98:11497.